Safety and tolerability of a multilineage-differentiating stress-enduring cell-based product in neonatal hypoxic-ischaemic encephalopathy with therapeutic hypothermia (SHIELD trial): a clinical trial protocol open-label, non-randomised, dose-escalation trial

Lignende værker

• Intravenously delivered multilineage-differentiating stress enduring cells dampen excessive glutamate metabolism and microglial activation in experimental perinatal hypoxic ischemic encephalopathy
  af: Suzuki, Toshihiko, et al.
  Udgivet: (2020)
• ET-67 SUICIDE GENE THERAPY FOR GLIOMA USING MULTILINEAGE-DEFFERENTIATING STRESS ENDURING (MUSE) CELLS
  af: Yamasaki, Tomohiro, et al.
  Udgivet: (2014)
• Multilineage-differentiating stress-enduring (Muse)-like cells exist in synovial tissue
  af: Eriko Toyoda, et al.
  Udgivet: (2019-06-01)
• Multilineage-differentiating stress-enduring (Muse)-like cells exist in synovial tissue
  af: Toyoda, Eriko, et al.
  Udgivet: (2018)
• Genetically Engineered Multilineage-Differentiating Stress-Enduring Cells as Cellular Vehicles against Malignant Gliomas
  af: Yamasaki, Tomohiro, et al.
  Udgivet: (2017)